NCT04911426

Brief Summary

The purpose of this study is to develop a clinical telehealth intervention and test the feasibility of integrating telehealth within a police opioid county diversion program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 3, 2021

Completed
11 days until next milestone

Study Start

First participant enrolled

June 14, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

April 18, 2025

Completed
Last Updated

April 18, 2025

Status Verified

April 1, 2025

Enrollment Period

2.1 years

First QC Date

April 5, 2021

Results QC Date

December 13, 2024

Last Update Submit

April 16, 2025

Conditions

Keywords

OpioidsTelehealthPolice diversion program

Outcome Measures

Primary Outcomes (2)

  • Percent of Participants Who Received One or More Referrals During the 12-week Intervention.

    The number of participants who received one or more referrals to services made by the intervention coach. This measure is collected as evidence supporting participant utilization of the app and the coaching support model.

    12-week intervention period

  • Texas Christian University Drug Screen 5 Severity Score From Baseline to Post Intervention at Week 12

    The Texas Christian University Drug Screen 5 is a 19-question survey that captures substance use during the past 12 months. Interpretation of the TCU Drug Screen 5 score for drug use severity corresponds with the Diagnostic and Statistical Manual of Mental Disorders 5 criteria for reporting three possible severity levels (mild, moderate, severe). A single level score is based on participant responses to 11 items (total range: 0 to 11) as such: the presence of 2 to 3 endorsed symptoms is scored as a mild disorder; 4 to 5 endorsed symptoms is scored as moderate disorder; and a severe disorder is scored with the presence of 6 or more symptoms of the 11 items; thus, more endorsed items means a more serious drug use problem.

    Texas Christian University Drug Screen 5 data are reported for baseline and end-of-intervention at 12 weeks after consent.

Study Arms (1)

Treatment plus telehealth

EXPERIMENTAL

Individuals will receive telehealth support services, including seven brief motivational interviewing sessions, delivered by a licensed substance use counselor via live interactive video calls during the 12-week intervention.

Behavioral: Telehealth

Interventions

TelehealthBEHAVIORAL

The telehealth intervention is delivered with an app developed for this research. The intervention features live video calling, messaging, appointment reminders; clinical support is provided by licensed clinicians.

Treatment plus telehealth

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals interested in joining the study will be
  • Enrolled in the A Way Out Opioid Diversion Program (ODP),
  • At least 18 years of age,
  • Able to speak and understand English,
  • Have a history of opioid, alcohol, or other substance use within last 12 months,
  • Be willing to provide the research team with access to treatment records,
  • Have access to a phone, tablet or computer for the informed consent activity, and
  • Have a mailing address to receive a study phone issued to consented participants

You may not qualify if:

  • Individuals not eligible for the study are
  • Not currently enrolled in the A Way Out Opioid Diversion Program on the day of consent,
  • Under the age of 18 on the day of consent,
  • Unable to speak and understand English,
  • Have a history of past opioid, alcohol, or other substance use longer than 12 months ago with no use of opioids in the last 12 months,
  • Unwilling to authorize the research team to access treatment records,
  • Without access to a phone, tablet or computer to complete the informed consent activity,
  • Without a mailing address

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lake County Public Health Department

Waukegan, Illinois, 60085, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Interventions

Telemedicine

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Limitations and Caveats

The T-CAP project explored the feasibility of implementing a telehealth model in a police diversion program that supports adults in recovery from opioid use disorder with treatment as an alternative to arrest. Inadequate data collection due to enrollment well below the target during the 2019 pandemic limits the ability to draw meaningful conclusions about the impact of the intervention to support people in recovery.

Results Point of Contact

Title
Dr.Jennifer Pankow
Organization
Texas Christian University Institute of Behavioral Research

Study Officials

  • Jennifer Pankow, PhD

    Texas Christian University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: The two-arm randomization has been discontinued with new consented participants joining the study in 2023.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2021

First Posted

June 3, 2021

Study Start

June 14, 2021

Primary Completion

July 31, 2023

Study Completion

July 31, 2023

Last Updated

April 18, 2025

Results First Posted

April 18, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations